75N94024R00001_Amendment_0003_FINAL_0003.pdf

(x)

75N94024R00001 x x copies of the amendment; (b) By acknowledging receipt of this amendment on each copy of the offer submitted ; or (c) By separate letter or electronic communication which includes a reference to the solicitation and amendment numbers. FAILURE OF YOUR ACKNOWLEDGEMENT TO BE

RECEIVED AT THE PLACE DESIGNATED FOR THE RECEIPT OF OFFERS PRIOR TO THE HOUR AND DATE SPECIFIED MAY RESULT IN REJECTION OF YOUR

OFFER. If by virtue of this amendment you desire to change an offer already submitted , such change may be made by letter or electronic communication, provided each letter or electronic communication makes reference to the solicitation and this amendment, and is received prior to the opening hour and date specified.

x

NICHD

Bethesda, MD 20892-7511 National Institute of Child Health National Institutes of Health

75N94024R0000103/28/2024

13. THIS ITEM ONLY APPLIES TO MODIFICATION OF CONTRACTS/ORDERS. IT MODIFIES THE CONTRACT/ORDER NO. AS DESCRIBED IN ITEM 14.

12. ACCOUNTING AND APPROPRIATION DATA (If required) is not extended.is extended, Items 8 and 15, and returning

Offers must acknowledge receipt of this amendment prior to the hour and date specified in the solicitation or as amended , by one of the following methods: (a) By completing

The above numbered solicitation is amended as set forth in Item 14. The hour and date specified for receipt of Offers

11. THIS ITEM ONLY APPLIES TO AMENDMENTS OF SOLICITATIONS

FACILITY CODE CODE

10B. DATED (SEE ITEM 13)

10A. MODIFICATION OF CONTRACT/ORDER NO.

9B. DATED (SEE ITEM 11)

9A. AMENDMENT OF SOLICITATION NO.

CODE

8. NAME AND ADDRESS OF CONTRACTOR (No., street, county, State and ZIP Code)

7. ADMINISTERED BY (If other than Item 6)CODE 6. ISSUED BY

PAGE OF PAGES

4. REQUISITION/PURCHASE REQ. NO.3. EFFECTIVE DATE2. AMENDMENT/MODIFICATION NO.

5. PROJECT NO. (If applicable)

1. CONTRACT ID CODE

AMENDMENT OF SOLICITATION/MODIFICATION OF CONTRACT

02/26/2024

CHECK ONE A. THIS CHANGE ORDER IS ISSUED PURSUANT TO: (Specify authority) THE CHANGES SET FORTH IN ITEM 14 ARE MADE IN THE CONTRACT

B. THE ABOVE NUMBERED CONTRACT/ORDER IS MODIFIED TO REFLECT THE ADMINISTRATIVE CHANGES (such as changes in paying office, C. THIS SUPPLEMENTAL AGREEMENT IS ENTERED INTO PURSUANT TO AUTHORITY OF:

D. OTHER (Specify type of modification and authority) appropriation data, etc.) SET FORTH IN ITEM 14, PURSUANT TO THE AUTHORITY OF FAR 43.103(b).

E. IMPORTANT: Contractor is not is required to sign this document and return __________________ copies to the issuing office.

ORDER NO. IN ITEM 10A.

16A. NAME AND TITLE OF CONTRACTING OFFICER (Type or print)15A. NAME AND TITLE OF SIGNER (Type or print)

15C. DATE SIGNED 16B. UNITED STATES OF AMERICA 15B. CONTRACTOR/OFFEROR 16C. DATE SIGNED

(Signature of person authorized to sign) (Signature of Contracting Officer)

TY B. MAIN

STANDARD FORM 30 (REV. 11/2016)

Prescribed by GSA FAR (48 CFR) 53.243

Previous edition unusable

14. DESCRIPTION OF AMENDMENT/MODIFICATION (Organized by UCF section headings, including solicitation/contract subject matter where feasible.)

This amendment provides responses to the questions received regarding this RFP. Please note that individual questions may have been combined or re-worded. The responses become a part of this RFP.

In addition, please note that the proposal due date remains April 12, 2024 at 4:00PM (EDT).

Estimated Period of Performance: 08/09/2024 to 08/08/2034

Except as provided herein, all terms and conditions of the document referenced in Item 9 A or 10A, as heretofore changed, remains unchanged and in full force and effect .

X

RFP: 75N94024R00001

AMENDMENT NO.: 0003

CONTINUATION PAGE

This amendment serves as clarification to the Government’s initial response addressing question #2, published in Amendment 0002 on March 26th, 2024.

Question:

“The work being conducted under this contract may involve the possession, use, or transfer of a select agent or toxin.” can you verify that the ability to work with select agents is a requirement for performance of tasks under this contract.

Answer:

There is no requirement for working with select agents. At times some of the samples might have select agents in them, but this is rare. We would not expect these samples to be opened or aliquoted.

CLARIFICATION:

Working with select agents is not required by the contract. While it is very rare, unexpected circumstances may arise where a sample contains a select agent. Currently, no toxins or special agents have been identified in our biospecimen collections. In the event a toxin or select agent is identified in the future, the contractor will not be required to open or aliquot these samples.

However, the contractor (including subcontractors) must adhere to the provisions outlined in

ARTICLE H.22. POSSESSION USE AND TRANSFER OF SELECT BIOLOGICAL AGENTS

OR TOXINS, which includes 42 CFR part 73, 7 CFR part 331, and/or 9 CFR part 121.

This amendment provides responses to the questions received regarding this RFP. Please note that individual questions may have been combined or re-worded. The responses become a part of this RFP.

END OF AMENDMENT